Aurobindo buys Europe operations from Apotex
Executive Summary
Aurobindo is set to expand its European footprint, “particularly in the generics market of Eastern Europe”, by signing a definitive agreement to acquire for €74 million (US$87 million) in cash Apotex’ businesses in five countries: Belgium, the Czech Republic, the Netherlands, Poland and Spain. Slated to close in the next three-to-six months, the acquisition is subject to clearance by Dutch and Polish competition authorities. Apotex intends to “focus its resources on the Americas, where strong demand for its portfolio continues”.